Navigation Links
Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
Date:7/24/2008

Pre-Clinical Data Shows Increased Muscle and Blood Vessel Formation in

Animals' Hearts

SUNRISE, Fla., July 24 /PRNewswire-FirstCall/ -- Results of a preclinical study involving the injection of myoblasts modified to express stromal derived factor-1(alpha) protein (SDF-1) into the scar tissue of the myocardium of rats, which suggest improved heart function, were recently presented at two scientific meetings -- the International Society for Magnetic Resonance in Medicine (ISMRM) in Toronto, and the American Society of Gene Therapy Meeting (ASGT) in Boston.

The data, presented by Bijoy Thattaliyath, MD, Post-doctoral Associate, Department of Pediatric Cardiology, University of Florida Health Science Center, showed a decrease of 0.02ml in end systolic volume (0.13ml to 0.11ml) and a 38 percent increase in stroke volume (0.31 ml to 0.43 ml) from three weeks post-myocardial infarction (MI, heart attack) to eight weeks post-cell transplantation, as presented in one of the SDF-1 modified myoblast (SDF-MB) transplanted animals. These results are indicative of 'positive remodeling', or return to normal heart function in the same period. Similar results were found in other study animals. Histopathology confirmed that myoblasts expressing SDF-1 resulted in increased muscle and blood vessel formation in the damaged areas of the hearts, which was not observed in the control.

Additionally, there was an 11.7 percent plus or minus 2.9 percent (p=0.02) absolute improvement in ejection fraction between three weeks post-MI and eight weeks post-cell transplantation in the SDF-MB treated animals. By comparison, and as anticipated, the control arm worsened in the same period. Ejection fraction is the percentage of blood pumped out of the heart's left ventricle with every heartbeat into the body's vasculature. A higher percent ejection fraction means more efficient heart function.

"The study data suggest that SDF-1 modified
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
4. GeoVax Reports Progress on Its AIDS Vaccine Technology
5. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
6. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
7. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
8. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
9. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
10. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...A, Switzerland, Nov. 25 From Nove...novative hearing solutions, presented the second e...focusing on the special needs of the older populat...ts in aging and audiology from around the world an...older people with hearing loss for an opportunity ...
(Date:11/25/2009)..., Nov. 25 The FDA granted traditio...ets, a non-nucleoside reverse transcriptase inhibi...lly indicated for use in treatment-experienced adu...V-1 strains resistant to an NNRTI and other antire...s based on 48-week data from two Phase 3 studies k...
(Date:11/25/2009)...Md., Nov. 25 Remedium T...ream-like foam that stops severe bleeding, won fir...y Idea category of the Global Security Challenge 2...ted from more than 100 entries from around the wor... GSC Security Summit conference held at the London...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 1Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 2Next Stage Solutions Announces Three New Financial Services For Emerging Business 12570 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 1TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 2TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 3TFAH Applauds Affordable Health Choices Act for Making Prevention a Cornerstone of Health Reform 48518 4More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 1More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 2More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 3More Than 9 in 10 Primary Care Physicians Say U S Health Care System Should Place Greater Emphasis on Nutrition to Manage Chronic Disease 48513 4
...ical Company,Limited (Takeda) announced today that...ch & Development Center, Inc. (U.S.), submitted a ...ug Administration (FDA) for,marketing approval of ...l),("alogliptin/ACTOS") in a single tablet for the...scovered by Takeda,s wholly owned subsidiary, Take...
...er Supports Spiriva,s Safety,Profile, RIDGEFIELD,...m and Pfizer Inc have released a new analysis of 3... UPLIFT, confirming the long term,safety profile o...alation,powder). The new and expanded safety data ... article by Singh et al. published in the Septembe...
Other Medicine Technology:Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 2Takeda Submits a New Drug Application in the U.S. for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 2Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 3Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 4Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT 5
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...K, Nov. 27 With cold and flu seaso... good practices to control the spread of infection...e not only to keep ourselves healthy, but to avoid...Finerty, RN, MS, CIC (certified in infection-contr...cupational health at Hospital for Special Surgery ...
(Date:11/26/2009)...ars, the number of Americans living with diabetes ...n 2009 to 44.1 million in 2034. Over the same peri...g from $113 billion to $336 billion, even with no ... based at the University of Chicago report in the ...of those with diabetes covered by Medicare will ri...
(Date:11/26/2009)...big or too heavy can lead to strains or worse , ...ere may be nothing wrong with stuffing your turkey...e same thing with your suitcase as you pack for ho...ated in 2008 in U.S. hospital emergency rooms, doc...s for luggage-related injuries, such as muscle str...
(Date:11/26/2009)... No more letters from the North Pole, Textsa... messages from Santa , No...perational efficiencies at the North Pole Santa Cl...dren all over the globe informed of his Christmas ...uo;s research department have identified a large a...
Breaking Medicine News(10 mins):Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...haway, John Legend and Wyclef Jean join Terrence H...p launch the new (2 WEEKS) T-Shirt and ...RANCISCO, Oct. 3 Gap is proud to,introduce its la...bovitz and featuring a diverse cast of,socially-co...
...esearch from the Howard Florey Institute in Melbou...use epilepsy in infants. , Infants are more susce...ping at a rapid rate, making their brain cells exc..., Infants have protective mechanisms in their bra...
...und pain, nervous disposition helps spur these out...erlying anxiety, pain and other behavioral or medi..., a new study suggests. , Researchers at the Unive...uarding of resources and territory" were the most ...
..., TORONTO, Oct. 3 /PRNewswire-FirstCall/ - Bradme... dedicated to the development and,commercializatio...,appointed Zafeer Ahmad, Ph.D, to the position of ...r effective,November 1, 2007. Chief Executive Offi...
..., AHF,s First in Kenya, is US AIDS Group,s 39th Gl...wide. New Kenyan Partnership Will, Provide Life- s...Mombasa, Kenya, where the National HIV/AIDS... Institute (KEMRI) to help save lives in Kenya by ...
...e Success Rate for Catheter Ablation Procedures Pe...ety of Cardiology Congress, ST. LOUIS, Oct. 3 St...presentation by Xu Chen, M.D., of the,Rigshospital...gation system. Dr. Chen presented the data at the ...
Other Medicine News:Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 2Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 3Health News:Gap Introduces Inspirational Marketing Campaign to Celebrate First Anniversary of Global Launch of Gap (PRODUCT) RED 4Health News:Research shows how genetic mutation causes epilepsy in infants 2Health News:Medical, Behavioral Woes Can Drive Dogs to Bite 2Health News:Bradmer announces management changes 2Health News:Bradmer announces management changes 3Health News:AHF and Kenya Medical Research Institute Partner to Save Lives at Free AIDS Treatment Clinic in Mombasa 2Health News:AHF and Kenya Medical Research Institute Partner to Save Lives at Free AIDS Treatment Clinic in Mombasa 3Health News:Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System 2Health News:Stereotaxis Highlights New Data on Acute Success in AFib Treatments With Niobe Magnetic Navigation System 3
Fineline EZ
Tendril DX Model 1388 K
Pediatric 6491
Flextend Model 4086
Medicine Products: